Background: Genetic abnormalities in the Fas receptor or its trimeric
ligand, Fast, result in massive T-cell proliferation and a lupus-like
autoimmune syndrome, which was initially attributed to excessive lymph
oproliferation but is now ascribed to the absence of Fas-mediated cell
death. Although Fas is normally expressed on most thymocyte, negative
selection seems to be unperturbed in Fas-deficient (lpr) mice, This s
uggests that Pas has an important function in peripheral, but not thym
ic, T cells. Results: To explore the Pas-mediated cell death pathway b
oth in vitro and in vivo, we used conditional alleles of the Fas recep
tor that can be triggered by an intracellularly active chemical induce
r of dimerization known as FK1012. We found that membrane attachment i
s important for Fas function and, unlike previous results with anti-fa
s monoclonal antibodies, we show that dimerization is sufficient to tr
igger apoptosis. Finally, the administration of FK1012 in vivo to tran
sgenic animals expressing the conditional Fas receptor in thymocytes d
emonstrates that sensitivity to Fas-mediated apoptosis is restricted t
o CD4(+) CD8(+) thymocytes. Conclusions: Here, we describe the first i
n vivo application of non-toxic, cell-permeable synthetic ligands to r
egulate signal transduction in transgenic mice expressing a conditiona
l receptor, Using this system, we show that the Fas pathway is restric
ted to double-positive thymocytes in vivo, consistent with recent in v
itro findings with thymocytes. This method promises to be useful not o
nly for developmental studies involving cell ablation, but also for st
udies involving the regulation of a wide variety of signaling molecule
s.